• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于新型腹膜联合透析液(1.36%葡萄糖/7.5%艾考糊精)的探索性研究表明,与单独研究的任何一种成分相比,其超滤效果有所改善。

An exploratory study of a novel peritoneal combination dialysate (1.36% glucose/7.5% icodextrin), demonstrating improved ultrafiltration compared to either component studied alone.

作者信息

Jenkins Sarah B, Wilkie Martin E

机构信息

Sheffield Kidney Institute, Northern General Hospital, Sheffield University Hospital Trust, Sheffield, South Yorkshire, United Kingdom.

出版信息

Perit Dial Int. 2003 Sep-Oct;23(5):475-80.

PMID:14604201
Abstract

OBJECTIVE

Concerns regarding the impact of ultrafiltration failure on peritoneal dialysis and the effect of hypertonic glucose on the peritoneal membrane have lead to a search for alternative dialysates. Computer simulations based on the three-pore theory suggest that a combination of 1.36% glucose and 7.5% icodextrin (glucose polymer) offers an improved ultrafiltration profile. The aim of the present study was to investigate the ultrafiltration profile of this combination fluid.

DESIGN

Prospective open study comparing 1.36% glucose, 3.86% glucose, 7.5% icodextrin, and the combination fluid (1.36% glucose/7.5% icodextrin).

SETTING

Sheffield Kidney Institute, Northern General Hospital, Sheffield, UK.

PATIENTS

11 patients currently using peritoneal dialysis not previously exposed to icodextrin.

MAIN OUTCOME MEASURE

Intraperitoneal volume was measured using a radioisotope dilution method.

RESULTS

The combination fluid showed a biphasic ultrafiltration profile, with a steep initial increase in intraperitoneal volume, then a maintained plateau phase for the duration of the study dwell (7 hours). The final volume was greater than that with the 1.36% glucose dwell and the 7.5% icodextrin dwell. The fluid was well tolerated by the patients.

CONCLUSIONS

These findings are in keeping with computer simulations using the three-pore model. The combination fluid offers an improved ultrafiltration profile, with a final volume similar to 3.86% glucose, while avoiding exposing the peritoneal membrane to high glucose concentrations. It may have a role as a long dwell to optimize ultrafiltration and possibly prolong peritoneal dialysis technique survival.

摘要

目的

关于超滤失败对腹膜透析的影响以及高渗葡萄糖对腹膜的作用的担忧促使人们寻找替代透析液。基于三孔理论的计算机模拟表明,1.36%葡萄糖和7.5%艾考糊精(葡萄糖聚合物)的组合可改善超滤情况。本研究的目的是调查这种混合液的超滤情况。

设计

前瞻性开放研究,比较1.36%葡萄糖、3.86%葡萄糖、7.5%艾考糊精和混合液(1.36%葡萄糖/7.5%艾考糊精)。

地点

英国谢菲尔德市北总医院谢菲尔德肾脏研究所。

患者

11名目前正在进行腹膜透析且此前未接触过艾考糊精的患者。

主要观察指标

采用放射性同位素稀释法测量腹腔内液体量。

结果

混合液呈现双相超滤情况,腹腔内液体量在开始时急剧增加,然后在研究留腹期(7小时)持续保持平稳阶段。最终液体量大于1.36%葡萄糖留腹和7.5%艾考糊精留腹时的量。患者对该液体耐受性良好。

结论

这些发现与使用三孔模型的计算机模拟结果一致。混合液可改善超滤情况,最终液体量与3.86%葡萄糖相似,同时避免使腹膜暴露于高葡萄糖浓度。它可能在长时间留腹中发挥作用,以优化超滤并可能延长腹膜透析技术的生存期。

相似文献

1
An exploratory study of a novel peritoneal combination dialysate (1.36% glucose/7.5% icodextrin), demonstrating improved ultrafiltration compared to either component studied alone.一项关于新型腹膜联合透析液(1.36%葡萄糖/7.5%艾考糊精)的探索性研究表明,与单独研究的任何一种成分相比,其超滤效果有所改善。
Perit Dial Int. 2003 Sep-Oct;23(5):475-80.
2
Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failure.腹膜透析超滤失败患者对艾考糊精良好反应的预测因素。
Nephrology (Carlton). 2005 Feb;10(1):33-6. doi: 10.1111/j.1440-1797.2005.00361.x.
3
Kinetic analysis of peritoneal fluid and solute transport with combination of glucose and icodextrin as osmotic agents.以葡萄糖和艾考糊精作为渗透剂联合使用时腹膜液和溶质转运的动力学分析
Perit Dial Int. 2009 Jan-Feb;29(1):72-80.
4
Enhanced ultrafiltration using 7.5% icodextrin/1.36% glucose combination dialysate: a pilot study.使用7.5%艾考糊精/1.36%葡萄糖混合透析液进行强化超滤:一项初步研究。
Perit Dial Int. 2004 Nov-Dec;24(6):542-6.
5
Automated peritoneal dialysis prescriptions for enhancing sodium and fluid removal: a predictive analysis of optimized, patient-specific dwell times for the day period.优化、个体化日间单次留腹时间以提高钠和液体清除率的自动化腹膜透析处方:预测分析。
Perit Dial Int. 2013 Nov-Dec;33(6):646-54. doi: 10.3747/pdi.2012.00261.
6
[Glucose polymer (icodextrin) as a component of fluid for peritoneal dialysis].[葡萄糖聚合物(艾考糊精)作为腹膜透析液的一种成分]
Pol Arch Med Wewn. 1998 May;99(5):417-22.
7
Randomized controlled trial of icodextrin versus glucose containing peritoneal dialysis fluid.含糖腹透液与艾考糊精腹透液随机对照试验
Clin J Am Soc Nephrol. 2009 Nov;4(11):1799-804. doi: 10.2215/CJN.02950509. Epub 2009 Oct 1.
8
Pharmacokinetics of icodextrin in peritoneal dialysis patients.艾考糊精在腹膜透析患者中的药代动力学
Kidney Int Suppl. 2002 Oct(81):S23-33. doi: 10.1046/j.1523-1755.62.s81.5.x.
9
Icodextrin metabolism and alpha-amylase activity in nonuremic rats undergoing chronic peritoneal dialysis.接受慢性腹膜透析的非尿毒症大鼠的艾考糊精代谢与α-淀粉酶活性
Perit Dial Int. 2007 Jul-Aug;27(4):415-23.
10
Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study.艾考糊精对容量状态、血压及超声心动图参数的影响:一项随机研究。
Kidney Int. 2003 Apr;63(4):1556-63. doi: 10.1046/j.1523-1755.2003.00887.x.

引用本文的文献

1
Biocompatible dialysis fluids for peritoneal dialysis.用于腹膜透析的生物相容性透析液。
Cochrane Database Syst Rev. 2018 Oct 26;10(10):CD007554. doi: 10.1002/14651858.CD007554.pub3.
2
Mechanisms of Crystalloid versus Colloid Osmosis across the Peritoneal Membrane.晶体液与胶体液跨腹膜渗透的机制。
J Am Soc Nephrol. 2018 Jul;29(7):1875-1886. doi: 10.1681/ASN.2017080828. Epub 2018 May 29.
3
Icodextrin and peritoneal dialysis: advantages and new applications.艾考糊精与腹膜透析:优势及新应用
Int Urol Nephrol. 2018 Mar;50(3):495-500. doi: 10.1007/s11255-017-1647-2. Epub 2017 Jul 3.
4
Future technologies and techniques in peritoneal dialysis-opportunities and challenges ahead.腹膜透析的未来技术与技巧——前方的机遇与挑战
NDT Plus. 2008 Oct;1(Suppl 4):iv51-iv55. doi: 10.1093/ndtplus/sfn125.
5
Bimodal solutions or twice-daily icodextrin to enhance ultrafiltration in peritoneal dialysis patients.双峰溶液或每日两次使用艾考糊精以增强腹膜透析患者的超滤作用。
Int J Nephrol. 2013;2013:424915. doi: 10.1155/2013/424915. Epub 2013 Jan 8.
6
Selection of modalities, prescription, and technical issues in children on peritoneal dialysis.儿童腹膜透析的方式选择、处方及技术问题
Pediatr Nephrol. 2009 Aug;24(8):1453-64. doi: 10.1007/s00467-008-0848-4. Epub 2008 Jun 3.